Journals / Gülhane Tıp Dergisi / 2018 / Cilt: 60 - Sayı: 3

Folic acid and zinc inhibit angiogenesis in chicken chorioallontoic membrane model via angiogenic factor genes

Pages
67–70
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

FGF2 gene was used by zinc in its inhibitory affect on the same panel.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: Angiogenesis occurs only in pathologic conditions such as wound healing and tumorogenesis.
📊
Key Findings & Data:Gene expression alterations were analyzed on FGF1, FGF2, VEGFA, VEGFR1, VEGFR2, and NRP1 genes by using c-DNAs as a template in real-time polymerase chain reactions.
💡
Conclusion & Impact:FGF2 gene was used by zinc in its inhibitory affect on the same panel.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aims: Angiogenesis occurs only in pathologic conditions such as wound healing and tumorogenesis. Folic acid is a form of a vitamin B. Zinc as an essential mineral plays an important role in tissue repair. Angiogenesis is an important process in wound healing and tissue repair. Despite of this, angiogenic role of folic acid/zinc is not clear on human body. Therefore, the possible angiogenic role of folic acid/zinc had been analyzed on an “in vivo” model in this manuscript. The gene expression alterations of angiogenic factors had been found in this panel. Methods: The possible roles of Folic acid and Zinc on angiogenesis were evaluated by using an “in vivo” model (chick embryo chorioallontoic membrane model). Total RNA isolation and c-DNA synthesis was performed from vascular structures. Gene expression alterations were analyzed on FGF1, FGF2, VEGFA, VEGFR1, VEGFR2, and NRP1 genes by using c-DNAs as a template in real-time polymerase chain reactions. The results in folic acid/zinc treated groups were correlated with the results in untreated groups for finding the gene expression alterations. Results: Folic acid and zinc in one by one and combined uses inhibited angiogenesis in certain concentrations. Folic acid inhibited the expressions of VEGFA, VEGFR1 and NRP1 genes. Zinc inhibited the expression of only FGF2 gene in our panel. Conclusions: In our study, antiangiogenic roles of folic acid and zinc were proven. Folic acid used VEGF-A, VEGFR1 and NRP1 genes in the inhibition of angiogenesis. FGF2 gene was used by zinc in its inhibitory affect on the same panel.

🔖

Cite This Article

GÜRAN, Ş., ÇOBAN, Z. D., FERMANLI, O., AYDINGÖZ, E., İPEK, E. (2018). Folic acid and zinc inhibit angiogenesis in chicken chorioallontoic membrane model via angiogenic factor genes. Gülhane Tıp Dergisi, Cilt: 60 - Sayı: 3, 67–70. https://ajindex.com/articles/167580

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Nowak-Sliwinska P, Segura T, Iruela-Arispe ML. The chicken chorioallantoic membrane model in biology, medicine and bioengineering. Angiogenesis 2014; 17(4): 779-804.
  2. Weinstein SJ, Hartman TJ, Stolzenberg-Solomon R, et al. Null association between prostate cancer and serum folate, vitamin B(6), vitamin B(12), and homocysteine. Cancer Epidemiol Biomarkers Prev. 2003; 12(11 Pt 1): 1271-1272.
  3. Ebisch IM, Thomas CM, Peters WH, Braat DD, Steegers-Theunissen RP. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update. 2007; 13(2): 163-174.
  4. Kuo CT, Chang C, Lee WS. Folic acid inhibits COLO205 colon cancer cell proliferation through activating the FRα/c-SRC/ERK1/2/NFκB/TP53 pathway: in vitro and in vivo studies. Sci Rep. 2015; 5(1): 11187. Pae M, Wu D. Nutritional modulation of age-related changes in the immune system and risk of infection. Nutr Res. 2017; 41(1):14-35.
  5. Swardfager W, Herrmann N, McIntyre R, et al. Potential roles of zinc in the pathophysiology and treatment of major depressive disorder. Neuroscience & Biobehavioral Reviews 2013; 37(5): 911–929.
  6. Flamme I, Frölich T, Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. Journal of cellular physiology 1997; 173 (2): 206–210.
  7. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005; 438 (7070): 967–974.
  8. Oosterbaan AM, Steegers EA, Ursem NT. The effects of homocysteine and folic acid on angiogenesis and VEGF expression during chicken vascular development. Microvasc Res. 2012; 83(2): 98-104.
  9. Ardlin BI, Dahl JE, Tibballs JE. Static immersion and irritation tests of dental metal-ceramic alloys. Eur J Oral Sci. 2005; 113(1): 83-89.
  10. Knighton D, Ausprunk D, Tapper D, Folkman J. Avascular and vascular phases of tumour growth in the chick embryo. Br J Cancer 1977; 35(3); 347-356. Ozgurtas T. An in vivo model for angiogenesis: chick chorioallantoic membrane. Gulhane Medical Journal [Gülhane Tıp Dergisi] 2009; 51(1): 67-69.
  11. Gulsen MR, Uzunay NS, Fermanlı O, et al. Anti-angiogenic role of Ankaferd on chick chorioallontoic membrane model. Gulhane Medical Journal [Gülhane Tıp Dergisi] 2015; 57(3): 274 – 279. Claesson-Welsh L, Welsh M. VEGFA and tumour angiogenesis. J Intern Med. 2013; 273(2): 114-127.
  12. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potent tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359(6398): 845-848. Ribatti D. The chick embryo chorioallantoic membran